Wildcat Capital Management, LLC Entera Bio Ltd. Transaction History

Wildcat Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$1.05 - $2.2 $137,472 - $288,037	-130,926 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$1.71 - $3.01 $83,106 - $146,286	-48,600 Reduced 27.07%	130,926 $269,000
Q4 2019 Feb 14, 2020	SELL	$1.84 - $2.97 $25,141 - $40,582	-13,664 Reduced 7.07%	179,526 $384,000
Q3 2019 Nov 14, 2019	SELL	$2.11 - $3.75 $21,100 - $37,500	-10,000 Reduced 4.92%	193,190 $481,000
Q4 2018 Feb 13, 2019	BUY	$3.0 - $5.85 $609,570 - $1.19 Million	203,190 New	203,190 $620,000

5.34M

2.6K

100

Ticker ENTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,809,900
Market Cap $49.8M
Description
Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed ...

Get notified when there are updates to the investment portfolio of Wildcat Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Wildcat Capital Management, LLC with notifications on news.